BCML vs AKBA

Comparison between BayCom Corp (BCML, Company) and Akebia Therapeutics Inc (AKBA, Company).

BCML is from the Financial Services sector, while AKBA is from the Healthcare sector.

5-Year PerformanceBCML has outperformed AKBA, delivering a return of +12.8% compared to -11.4%

BCML vs AKBA - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	BCML(COMPANY)	AKBA(COMPANY)
Market Cap	$335M	$338M
Max Drawdown	62.19%	99.14%
Sharpe Ratio	0.51	-0.90
5Y Beta	0.69	1.28
Industry	Banks - Regional	Drug Manufacturers - Specialty & Generic
P/E Ratio	12.71	-16.37
Forward P/E	11.86	28.74
PEG Ratio	0.85	0.00
Dividend Yield	3.74%	N/A
5Y EPS CAGR	12.84%	-35.14%
Debt to Equity	0.00%	178.59%
Free Cash Flow Yield	8.08%	17.79%
P/S Ratio	3.50	1.45
P/B Ratio	1.00	12.49

Market Cap

BCML

$335M

Winner

AKBA

$338M

Max Drawdown

Winner

BCML

62.19%

AKBA

99.14%

Sharpe Ratio

Winner

BCML

0.51

AKBA

-0.90

5Y Beta

Winner

BCML

0.69

AKBA

1.28

Industry

BCML

Banks - Regional

AKBA

Drug Manufacturers - Specialty & Generic

P/E Ratio

BCML

12.71

Winner

AKBA

-16.37

Forward P/E

Winner

BCML

11.86

AKBA

28.74

PEG Ratio

BCML

0.85

Winner

AKBA

0.00

Dividend Yield

BCML

3.74%

AKBA

N/A

5Y EPS CAGR

Winner

BCML

12.84%

AKBA

-35.14%

Debt to Equity

Winner

BCML

0.00%

AKBA

178.59%

Free Cash Flow Yield

BCML

8.08%

Winner

AKBA

17.79%

P/S Ratio

BCML

3.50

Winner

AKBA

1.45

P/B Ratio

Winner

BCML

1.00

AKBA

12.49

BCML vs AKBA - Historical Returns

Returns include dividend reinvestment.

Period	BCML	AKBA
1 month	-8.18%	+18.42%
3 months	+1.71%	-2.17%
6 months	+5.59%	-4.26%
1 year	+17.18%	-63.11%
5 years(CAGR)	+12.81%	-11.38%
10 years(CAGR)	+10.41%	-17.23%
Max(CAGR)	+5.65%	-21.45%

BCML

-8.18%

Winner

AKBA

+18.42%

Winner

BCML

+1.71%

AKBA

-2.17%

Winner

BCML

+5.59%

AKBA

-4.26%

Winner

BCML

+17.18%

AKBA

-63.11%

5Y(CAGR)

Winner

BCML

+12.81%

AKBA

-11.38%

10Y(CAGR)

Winner

BCML

+10.41%

AKBA

-17.23%

Max(CAGR)

Winner

BCML

+5.65%

AKBA

-21.45%

BCML vs AKBA - Annual Returns (2004 - 2026)

Returns include dividend reinvestment.

Year	BCML	AKBA
2026	+6.91%	-12.90%
2025	+15.80%	-15.26%
2024	+17.46%	+49.61%
2023	+26.88%	+99.20%
2022	+2.02%	-76.45%
2021	+25.57%	-22.74%
2020	-32.88%	-55.84%
2019	+1.61%	+8.97%
2018	+18.71%	-63.06%
2017	+30.36%	+41.62%
2016	+12.15%	-17.12%
2015	+11.34%	+12.35%
2014	+22.68%	-56.40%
2013	+18.29%	N/A
2012	+19.71%	N/A
2011	-2.00%	N/A
2010	-9.81%	N/A
2009	+9.15%	N/A
2008	-32.38%	N/A
2007	-11.39%	N/A
2006	-1.25%	N/A
2005	-7.69%	N/A
2004	+30.00%	N/A

BCML vs AKBA Drawdown Comparison

The maximum drawdown for BCML was -62.19%, occurring on Sep 25, 2020. Recovery took 1561 trading sessions.

The maximum drawdown for AKBA was -99.14%, occurring on Nov 29, 2022. This drawdown has not yet recovered.

The current BCML drawdown is -13.16%. The current AKBA drawdown is -95.37%.

Rank	BCML	AKBA
#1	-62.19% Aug 23, 2018 - Nov 6, 2024	-99.14% Jun 20, 2014 - Nov 29, 2022
#2	-58.62% Oct 15, 2004 - Dec 22, 2016	-36.84% Mar 20, 2014 - Apr 21, 2014
#3	-18.03% Nov 26, 2024 - Aug 22, 2025	-21.82% Apr 21, 2014 - Jun 9, 2014
#4	-14.29% Dec 17, 2025 - Apr 9, 2026	-4.91% Jun 9, 2014 - Jun 20, 2014
#5	-13.59% Apr 9, 2026 - Jun 24, 2026	N/A
#6	-13.16% Jul 16, 2026 - Jul 30, 2026	N/A
#7	-11.80% Sep 18, 2025 - Dec 10, 2025	N/A
#8	-9.15% Mar 21, 2018 - May 17, 2018	N/A
#9	-6.78% Jun 4, 2018 - Aug 6, 2018	N/A
#10	-3.96% May 17, 2018 - Jun 4, 2018	N/A
#11	-3.85% Sep 15, 2004 - Sep 27, 2004	N/A
#12	-3.28% Mar 17, 2017 - Apr 24, 2017	N/A
#13	-2.69% Mar 1, 2017 - Mar 17, 2017	N/A
#14	-2.62% Aug 26, 2025 - Sep 18, 2025	N/A
#15	-2.58% Jun 27, 2017 - Sep 27, 2017	N/A

Correlation

Correlation between BCML and AKBA is -0.53 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.53

-101